Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Author:

James Stefan12,Erlinge David3,Storey Robert F.45,McGuire Darren K.67,de Belder Mark8,Eriksson Niclas1,Andersen Kasper29,Austin David1011,Arefalk Gabriel912,Carrick David1314,Hofmann Robin15,Hoole Stephen P.16,Jones Daniel A.1718,Lee Kelvin1920,Tygesen Hans2122,Johansson Peter A.23,Langkilde Anna Maria23,Ridderstråle Wilhelm23,Parvaresh Rizi Ehsan23,Deanfield John24,Oldgren Jonas12

Affiliation:

1. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

2. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden

3. Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden

4. Cardiovascular Research Unit, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom

5. NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

6. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas

7. Division of Cardiology, Parkland Health and Hospital System, Dallas

8. National Institute for Cardiovascular Outcomes Research (NICOR), NHS Arden & GEM Commissioning Support Unit, Leicester, United Kingdom

9. Department of Medical Sciences, Clinical Epidemiology, Uppsala University, Uppsala, Sweden

10. Academic Cardiovascular Unit, The James Cook University Hospital, South Tees NHS FT, Middlesbrough, United Kingdom

11. Population Health Science Institute, Newcastle University, Newcastle, United Kingdom

12. Thoracic Center, Blekinge Hospital, Karlskrona, Sweden

13. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

14. Department of Cardiology, University Hospital Hairmyres, East Kilbride, United Kingdom

15. Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm

16. Department of Interventional Cardiology, Royal Papworth Hospital, Cambridge, United Kingdom

17. William Harvey Research Institute, Barts & The London Faculty of Medicine & Dentistry, Queen Mary University of London, London

18. Department of Cardiology, St. Bartholomew’s Hospital, West Smithfield, London

19. Lincolnshire Heart Centre, United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom

20. School of Life Sciences, University of Lincoln, Lincoln, United Kingdom

21. Department of Medicine, South Älvsborg Hospital, Borås, Sweden

22. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden

23. Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden

24. Institute of Cardiovascular Sciences, University College London, London

Publisher

Massachusetts Medical Society

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3